Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17519
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAl-Bassam, Wisam-
dc.contributor.authorKubicki, Mark-
dc.contributor.authorBailey, Michael-
dc.contributor.authorWalker, Laurence-
dc.contributor.authorYoung, Paul-
dc.contributor.authorPilcher, David V-
dc.contributor.authorBellomo, Rinaldo-
dc.date2018-
dc.date.accessioned2018-04-24T06:54:31Z-
dc.date.available2018-04-24T06:54:31Z-
dc.date.issued2018-01-07-
dc.identifier.citationJournal of Critical Care 2018; 45: 90-94-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/17519-
dc.description.abstractThere are limited data on the characteristics, incidence, and mortality of patients with myasthenia gravis (MG) admitted to the ICU. To study the epidemiology, characteristics and outcome of patients with MG in Australian and New Zealand (ANZ) ICUs over a decade. We performed a retrospective observational, cross sectional study of data from the Australian and New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD). We collected data on all adult patients admitted with a primary diagnosis of MG to 159 Australian and 19 New Zealand ICUs between January 1, 2005 and December 31, 2015.We extracted detailed relevant data and performed statistical assessment. We identified 245 patients admitted to ICU with the primary diagnosis of MG, with an incidence increasing from 1 to 2.5 per thousand ICU admissions (P<0.0001) and from 1 to 2.2 per million people (P=0.02). Mean age was 60years with more patients being female (53.7% vs 47.3%) and 91 (37.1%) patients received mechanical ventilation. Hospital mortality occurred in 13 (5.3%) patients with a mortality rate lower than in other ICU patients. In ANZ, the ICU and population incidence of MG has increased over the last decade. However, its mortality rate was low.-
dc.language.isoeng-
dc.titleCharacteristics, incidence, and outcome of patients admitted to the intensive care unit with myasthenia gravis.-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of Critical Care-
dc.identifier.affiliationDepartment of Intensive Care, Austin Health, Heidelberg, Victoria, Australia-
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Alfred Hospital, Commercial Rd, Melbourne, Australia-
dc.identifier.affiliationCardiothoracic and Vascular Intensive Care Unit, Auckland City Hospital, Auckland, New Zealand; Medical Research Institute of New Zealand, Wellington, New Zealand-
dc.identifier.affiliationMedical Research Institute of New Zealand, Wellington, New Zealand; Intensive Care Unit, Wellington Hospital, Wellington, New Zealand-
dc.identifier.affiliationAustralian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation, Melbourne, Australia-
dc.identifier.doi10.1016/j.jcrc.2018.01.003-
dc.identifier.orcid0000-0002-1650-8939-
dc.identifier.pubmedid29413729-
dc.type.austinJournal Article-
local.name.researcherAl-Bassam, Wisam
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairetypeJournal Article-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.